Aug 5, 2026 04:00PM
Jul 16, 2026 09:00AM
Jul 16, 2026 09:00AM
Jul 8, 2026 08:00AM
Jul 8, 2026 08:00AM
Jun 30, 2026 09:17AM
Jun 30, 2026 09:15AM Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
Jun 29, 2026 07:06PM
Jun 29, 2026 07:06PM
May 6, 2026 04:00PM
Apr 27, 2026 08:01AM
Apr 27, 2026 08:00AM
Apr 22, 2026 08:04AM
Apr 22, 2026 08:00AM Arcutis’ ZORYVE® (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines
Apr 8, 2026 09:15AM
Apr 7, 2026 12:26PM
Apr 7, 2026 07:30AM
Mar 28, 2026 11:00AM
Mar 28, 2026 11:00AM
Mar 18, 2026 08:00AM
Mar 10, 2026 09:00AM Arcutis publishes long-term ZORYVE safety data for pediatric atopic dermatitis
Mar 10, 2026 09:00AM
Mar 5, 2026 09:01AM
Mar 5, 2026 09:00AM
Feb 25, 2026 04:00PM
Feb 24, 2026 09:15AM
Feb 2, 2026 08:00AM
Feb 2, 2026 08:00AM Arcutis Announces Positive Topline Results for INTEGUMENT-INFANT Phase 2 Trial of ZORYVE® (roflumilast) Cream 0.05% in Infants with Mild to Moderate Atopic Dermatitis
Jan 12, 2026 08:10AM
Jan 12, 2026 08:00AM
Dec 21, 2025 08:00PM
Nov 17, 2025 08:04AM
Nov 17, 2025 08:00AM
Nov 13, 2025 08:00AM
Nov 13, 2025 08:00AM Arcutis Completes Enrollment in INTEGUMENT-INFANT Phase 2 Study Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
Nov 4, 2025 08:04AM
Nov 4, 2025 08:00AM
Oct 30, 2025 09:15AM
Oct 30, 2025 08:03AM
Oct 30, 2025 08:00AM
Oct 28, 2025 08:34AM
Oct 28, 2025 08:30AM Arcutis Outlines Strategy for Driving Sustainable Growth and Announces Third Quarter 2025 Financial Results
Oct 24, 2025 08:00AM
Oct 24, 2025 08:00AM
Oct 6, 2025 08:00AM
Oct 6, 2025 08:00AM
Sep 17, 2025 04:00AM
Sep 16, 2025 09:00AM
Sep 3, 2025 11:44AM Arcutis submits application to expand ZORYVE for children ages 2-5
Sep 3, 2025 11:43AM

328,143 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All